The case of the first deceased in Peru is presented. 78-year-old man, with a history of hypertension, who presented a characteristic clinical picture of the disease caused by the new coronavirus (COVID-19), which had fundamental epidemiological data, the positive confirmatory test together with some laboratory parameters and radiological image also characteristic; that followed a fatal evolution, despite receiving the recommended therapy at that time. This case highlighted the need to quickly identify those patients who could have an unfavorable evolution, in order to provide the earliest and most adequate treatment.

We present the case of a 44-year-old male patient, health personnel with high blood pressure, who had contact with patients with COVID-19 pneumonia. He had rapidly clinically-radiologically progressive lung involvement, received evidence-based treatment at admission, and an interleukin-6 receptor antagonist (tocilizumab) for compassionate use, obtaining a favorable clinical response.

We present nine cases of COVID-19 patients that developed pneumonia caused by SARSCov-2 who were seen in the Peruvian Central Air Force Hospital and showed different clinical features, risk factors, and outcomes. Findings of their thorax CT scans are described using a tomographic score that was applied on admission. Points assigned were based on the percentage of involvement on each pulmonary lobe and this allowed us to determine a clinical diagnosis of pneumonia according to its severity, even before having positive results in molecular and serological tests for some of these patients.

We present nine cases of COVID-19 patients that developed pneumonia caused by SARSCov-2 who were seen in the Peruvian Central Air Force Hospital and showed different clinical features, risk factors, and outcomes. Findings of their thorax CT scans are described using a tomographic score that was applied on admission. Points assigned were based on the percentage of involvement on each pulmonary lobe and this allowed us to determine a clinical diagnosis of pneumonia according to its severity, even before having positive results in molecular and serological tests for some of these patients.

ObjetivoDeterminar algunas características clínicas y epidemioló­gicas de la Tuberculosis extrapulmonar (TBC EP).MétodoEstudio descriptivo, retrospectivo, transversal. Se revisa­ron 96 historias clínicas con diagnóstico de TBC EP, to­madas del Registro del Programa de Control de TBC, du­rante el período: Enero 1997 - diciembre 2001, en el Hos­pital Central de la Fuerza Aérea del Perú (HCFAP).ResultadosDel total de casos de TBC, se presentó TBC EP en 150/532 (28.03%). Fueron evaluados 96 casos, según su localización se diagnosticó: TBC pleural (67.7%), gan­glionar (6%), enteroperitoneal (6%), ósea (4%), genitou­rinario (4%), cerebral (4%), cutánea (3%), pericárdica (2%), miliar (1%) y trompas uterinas (1%). Varones 70%. La edad media fue 33.8 arios (70% < 34 arios), 83.5% procedían de Lima. Estudiantes y personal de tropa fue­ron 51.7%. Contacto TBC previo 52.4...

El documento digital no refiere asesor